- Home
- Publications
- Publication Search
- Publication Details
Title
Fenofibrate
Authors
Keywords
-
Journal
DRUGS
Volume 71, Issue 14, Pages 1917-1946
Publisher
Springer Nature
Online
2011-10-05
DOI
10.2165/11208090-000000000-00000
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolic and monocyte-suppressing actions of fenofibrate in patients with mixed dyslipidemia and early glucose metabolism disturbances
- (2014) Robert Krysiak et al. Pharmacological Reports
- Efficacy and Safety of Coadministration of Fenofibrate and Ezetimibe Compared with Each as Monotherapy in Patients with Type IIb Dyslipidemia and Features of the Metabolic Syndrome
- (2013) Jean-Claude Ansquer et al. American Journal of Cardiovascular Drugs
- Effect of Simvastatin and Fenofibrate on Cytokine Release and Systemic Inflammation in Type 2 Diabetes Mellitus With Mixed Dyslipidemia
- (2011) Robert Krysiak et al. AMERICAN JOURNAL OF CARDIOLOGY
- Fenofibrate
- (2011) Gillian M. Keating American Journal of Cardiovascular Drugs
- Triglycerides and Cardiovascular Disease
- (2011) Michael Miller et al. CIRCULATION
- Fixed-Dose Combination Fenofibrate/Pravastatin 160/40 mg Versus Simvastatin 20 mg Monotherapy in Adults With Type 2 Diabetes and Mixed Hyperlipidemia Uncontrolled With Simvastatin 20 mg: A Double-Blind, Randomized Comparative Study
- (2011) Michel Farnier et al. CLINICAL THERAPEUTICS
- Fenofibric acid prevents retinal pigment epithelium disruption induced by interleukin-1β by suppressing AMP-activated protein kinase (AMPK) activation
- (2011) M. Villarroel et al. DIABETOLOGIA
- ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
- (2011) et al. EUROPEAN HEART JOURNAL
- Pharmacoepidemiology Safety Study of Fibrate and Statin Concomitant Therapy
- (2010) Cheryl Enger et al. AMERICAN JOURNAL OF CARDIOLOGY
- Efficacy and Safety of Adding Fenofibrate 160 mg in High-Risk Patients With Mixed Hyperlipidemia Not Controlled by Pravastatin 40 mg monotherapy
- (2010) Michel Farnier et al. AMERICAN JOURNAL OF CARDIOLOGY
- Optimal pharmacologic approach to patients with hypertriglyceridemia and low high-density lipoprotein-cholesterol: Randomized comparison of fenofibrate 160mg and niacin 1500mg
- (2010) Jin Wi et al. ATHEROSCLEROSIS
- Effects of fenofibrate therapy on circulating adipocytokines in patients with primary hypertriglyceridemia
- (2010) Kwang Kon Koh et al. ATHEROSCLEROSIS
- Effects of Combination Lipid Therapy in the Management of Patients With Type 2 Diabetes Mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
- (2010) Andrew M. Tonkin et al. CIRCULATION
- Fenofibrate improves endothelial function in the brachial artery and forearm resistance arterioles of statin-treated Type 2 diabetic patients
- (2010) Sandra J. Hamilton et al. CLINICAL SCIENCE
- Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: A 12-week, multicenter, double-blind, randomized, parallel-group study
- (2010) Michael H. Davidson et al. CLINICAL THERAPEUTICS
- Implications of the ACCORD Lipid study: perspective from the Residual Risk Reduction Initiative (R3i)
- (2010) J.C. Fruchart et al. CURRENT MEDICAL RESEARCH AND OPINION
- Role of fibrates in cardiovascular disease prevention, the ACCORD-Lipid perspective
- (2010) Marshall Elam et al. CURRENT OPINION IN LIPIDOLOGY
- Pleiotropic Effects of Atorvastatin and Fenofibrate in Metabolic Syndrome and Different Types of Pre-Diabetes
- (2010) R. Krysiak et al. DIABETES CARE
- Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
- (2010) P. L. Drury et al. DIABETOLOGIA
- Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study
- (2010) T. M. E. Davis et al. DIABETOLOGIA
- Fenofibrate Reduces Systemic Inflammation Markers Independent of Its Effects on Lipid and Glucose Metabolism in Patients with the Metabolic Syndrome
- (2010) Renata Belfort et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of Gemfibrozil and Fenofibrate on the Pharmacokinetics of Atorvastatin
- (2010) Lloyd R. Whitfield et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Fenofibrate suppresses microvascular inflammation and apoptosis through adenosine monophosphate–activated protein kinase activation
- (2010) Atsuko Tomizawa et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Method to Adjust Efficacy Estimates for Uptake of Other Active Treatments in Long-Term Clinical Trials
- (2010) John Simes et al. PLoS One
- Peroxisome proliferator-activated receptor-alpha (PPARα): At the crossroads of obesity, diabetes and cardiovascular disease
- (2009) Jean-Charles Fruchart ATHEROSCLEROSIS
- Effects of atorvastatin 10 mg and fenofibrate 200 mg on the low-density lipoprotein profile in dyslipidemic patients: A 12-week, multicenter, randomized, open-label, parallel-group study
- (2009) Jean-Claude Ansquer et al. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
- Regulatory Effects of Fenofibrate and Atorvastatin on Lipoprotein A-I and Lipoprotein A-I:A-II Kinetics in the Metabolic Syndrome
- (2009) D. C. Chan et al. DIABETES CARE
- Advances in the Medical Treatment of Diabetic Retinopathy
- (2009) R. Simo et al. DIABETES CARE
- Preventing diabetic complications: A primary care perspective
- (2009) Paul Zimmet DIABETES RESEARCH AND CLINICAL PRACTICE
- Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
- (2009) D. C. Burgess et al. EUROPEAN HEART JOURNAL
- Clinical insights from the Fenofibrate Intervention and Event Lowering in Diabetes study: a community practice perspective
- (2009) P. P. Toth INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial
- (2009) Kushwin Rajamani et al. LANCET
- Fenofibrate reduces lipoprotein associated phospholipase A 2 mass and oxidative lipids in hypertriglyceridemic subjects with the metabolic syndrome
- (2008) Robert S. Rosenson AMERICAN HEART JOURNAL
- Expert Perspective: Reducing Cardiovascular Risk in Metabolic Syndrome and Type 2 Diabetes Mellitus Beyond Low-Density Lipoprotein Cholesterol Lowering
- (2008) Peter H. Jones AMERICAN JOURNAL OF CARDIOLOGY
- Atorvastatin and Fenofibrate Have Comparable Effects on VLDL-Apolipoprotein C-III Kinetics in Men With the Metabolic Syndrome
- (2008) Dick C. Chan et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
- (2008) R. Scott et al. DIABETES CARE
- Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes: the Fremantle Diabetes Study
- (2008) T. M. E. Davis et al. DIABETOLOGIA
- Lipoprotein Management in Patients With Cardiometabolic Risk
- (2008) John D. Brunzell et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- PPARα activators upregulate eNOS activity and inhibit cytokine-induced NF-κB activation through AMP-activated protein kinase activation
- (2008) Toshie Okayasu et al. LIFE SCIENCES
- Effect of Fenofibrate on Adiponectin and Inflammatory Biomarkers in Metabolic Syndrome Patients
- (2008) Robert S. Rosenson Obesity
- Effect of fenofibrate therapy on paraoxonase1 status in patients with low HDL-C levels
- (2007) Wimon Phuntuwate et al. ATHEROSCLEROSIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now